Showing 21 - 33 of 33 results
PET innovation
Tool developed for producing F-18 radiopharmaceuticals for PET imaging.
Role at ANSTO
Symposium on advanced therapy
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
Australian access to overseas synchrotrons
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
Giant clams open up climate secrets
ANSTO facilities and expertise supply a large range of radioisotopes for radiopharmaceutical and environmental applications
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
Jarosite on Earth and Mars
Useful in some mineral processes but a major problem in others, jarosite may be the key to unlocking the geological history and environmental context of water on Mars.
Insights into Titan’s atmosphere
Terahertz/Far Infrared beamlines assisted investigation into possible composition of lower atmosphere of Saturn's moon Titan.
Digestive brilliance of breast milk revealed
Innovative technology provides enhancement to advanced radiation therapy
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
Publications
Publications and resources from the Powder Diffraction beamline.
Advanced Diffraction & Scattering Beamlines (ADS-1 and ADS-2) UNDER CONSTRUCTION
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.